bioRxiv Science⌕ Search

Biology subjects

Ackers-Johnson, M. A.

Publications and source records attributed to Ackers-Johnson, M. A..

2 recordsLinked to original sources

High throughput single-cell RNA sequencing of intact adult cardiomyocytes and non-myocytes using a split-pool approach

MOTIVATIONAdult cardiomyocytes are difficult to profile by whole-cell single-cell RNA sequencing because of their large size and fragility, which make them poorly compatible with standard workflows. Current approaches for adult cardiomyocyte transcriptomics often require a trade-off between data quality and throughput, thus, studies instead rely heavily on sequencing of nuclei alone. Therefore, we set out to develop a high-quality and scalable workflow for adult heart cells using in-cell ligation and split-pool barcoding strategies to address this methodological gap. This workflow may be further generalisable to other large cell types or samples containing cell populations with highly unequal RNA content. SUMMARYAdult cardiomyocytes are difficult to profile by whole-cell single-cell RNA sequencing (scRNA-seq). Here, we developed a high-quality and scalable workflow for adult heart cells using in-cell ligation and split-pool barcoding. We identified per-cell RNA content as a significant variable that must be accounted for. Separation of cardiomyocytes (large cells) and non-cardiomyocytes (small cells) before library construction, and allocation of deeper sequencing to cardiomyocytes, produced high-quality whole-cell datasets for both compartments. Compared with single-nucleus RNA sequencing, whole-cell cardiomyocyte profiling better recovered metabolic, mitochondrial, cytoplasmic translational, and contractile gene programs. This workflow provides a practical method for scalable, high-quality cardiomyocyte whole-cell scRNA-seq and offers general strategies for other large cell types or samples containing cell populations with highly unequal RNA content.

cell biology↗

Chromatin landscape and enhancer-gene interactiondifferences between three cardiac cell types

Genome-wide association studies (GWAS) have identified numerous single nucleotide polymorphisms (SNP) associated with a specific traits and diseases, however, uncovering the true disease-relevant SNPs remains challenging. One limitation for prioritizing true disease-relevant SNPs from GWAS is that most of the identified SNPs are non-coding, making it difficult to unravel their mechanism of action. Nevertheless, mapping non-coding SNPs to enhancers is a validated approach to link SNPs to their target genes through the analysis of enhancer-gene interactions (EGI) and thus provide insight into their mechanism of action. While previous studies linking cardiac disease-relevant SNPs to enhancers and their target genes have focused on the principal cardiac cell type, cardiomyocytes (CMs), the analysis of other non-CM cell types has been largely ignored and has only gained attention recently. We hypothesize that characterizing cell-type-specific enhancer-gene interactions (EGIs) for these non-CMs, namely cardiac fibroblasts (CFs), endothelial cells (ECs), and smooth muscle cells (SMCs), followed by mapping cardiac-disease-associated non-coding SNPs to those enhancers will identify novel disease-relevant genes and provide insights for future mechanistic research. To identify the landscape of cell-type-specific EGIs in these cardiac cells, we have employed the activity-by-Contact (ABC) model. It integrates assay for transposase-accessible chromatin sequencing (ATAC-seq), H3K27ac chromatin immunoprecipitation with sequencing (ChIP-seq), and high-throughput chromosome conformation capture with H3K27ac immunoprecipitation (H3K27ac HiChIP) data to identify EGIs. We have identified the landscape of cell-type-specific EGIs in these cardiac cells. Furthermore, a higher similarity of the chromatin accessibility profile (ATAC-seq) between CF and SMC, compared to CF and EC, and SMC and EC was observed. Finally, overlapping identified EGIs with cardiac-disease-associated non-coding variants has allowed the identification of a QT-interval-associated SNP that is mapped to the enhancer region of an EC-specific EGI.

genomics↗